Corporate Statement

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Overview

News Releases

17 Aug '22
DUBLIN , Aug. 17, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) (" Mallinckrodt " or the "Company"), a global specialty pharmaceutical company, today announced that Karen Ling has been appointed to the Company's Board of Directors, effective August 12, 2022 . With the addition of Ms.
23 Jun '22
-Post-hoc analyses showcase Mallinckrodt's commitment to patients with HRS involving rapid reduction in kidney function, 1 an acute and life-threatening condition 2 - DUBLIN , June 23, 2022 /PRNewswire/ --  Mallinckrodt plc  (OTCMKTS: MNKPF), a global biopharmaceutical company, today announced two

Recent Events

Featured Reports

go back to the top of the page